Acute pandysautonomia: Mass spectrometric and histopathological studies of the sympathetic nervous system during long term L-threo-3,4-dihydroxyphenylserine treatment

Journal of Neurology Neurosurgery and Psychiatry

Volumn 61, Issue 1, 1996, Pages 99-102

  Ushiyama, Masao ^a   Ikeda, Shu Ichi ^b   Suzuki, Tomokazu ^c   Yazawa, Masanobu ^d   Yanagisawa, Nobuo ^b   Tsujino, Sei Ichi ^e  

^a Kenwakai Hospital   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d Fujimikogen Hospital

^e OSAKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Acute pandysautonomia; Noradrenaline; Orthostatic hypotension

Indexed keywords

HYDROXYAMINO ACID; NORADRENALIN; THREO 3,4 DIHYDROXYPHENYLSERINE;

ADRENERGIC SYSTEM; ADULT; ARTICLE; BLOOD PRESSURE; CASE REPORT; DYSAUTONOMIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MASS SPECTROMETRY; NEUROPATHOLOGY; NORADRENERGIC NERVE; PRIORITY JOURNAL; RECTUM MUCOSA;

EID: 0030015799     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.61.1.99     Document Type: Article

References (12)

1. Young RR, Asbury AK, Adams RD, Corbett JL. Pure pandysautonomia with recovery. Trans Am Neurol Assoc 1969;94:355-7.
2. Kita K, Hirayama K, Ito N. Acute idiopathic pandysautonomia: clinical features, laboratory studies and criteria. In: Sobue I, Tsubaki T, Kuroiwa Y, et al, eds. Peripheral neuropathy. Amsterdam: Excerpta Medica, 1984:151-64.
3. Suzuki T, Sakoda S, Ueji M, Kishimoto S. Mass spectrometric measurements of norepinephrine synthesis in man from infusion of stable isotope labelled L-threo-3,4-dihydroxyphenylserine. Life Sci 1985;36:435-42.
4. Suzuki T, Higa S, Tsuge I, et al. Effect of infused L-threo-3,4-dihydroxyphenylserine on adrenergic activity in patients with familial amyloid polyneuropathy. Eur J Clin Pharmacol 1980;17:429-35.
5. Ikeda S, Oguchi K, Kobayashi S, Tsukahara S, Yanagisawa N. Histochemical study of rectal aminergic nerves in type I familial amyloid polyneuropathy. Neurology 1983;33: 1055-8.
6. Yazawa M, Ikeda S, Ushiyama M, Yanagisawa N. Noradrenergic nerve fibers of the rectal mucosa in autonomic disorders: comparison of histochemical study with clinical severity and changes in plasma noradrenaline induced by standing. J Neurol Sci 1991;104:222-9.
7. Yazawa M, Ikeda S, Yanagisawa N. Extrinsic and intrinsic nerve lesions of the intestine in type I familial amyloid polyneuropathy. In: Natvig JB, Førre O, Husby G, et al, eds. Amyloid and amyloidosis 1990. Dordrecht: Kluwer Academic Publishers, 1991:683-6.
8. Yanaihara N, Yanaihara C, Nokihara K, et al. Immunochemical study on PHI/PHM with use of synthetic peptides. Peptides 1984;5:247-54.
9. Suzuki T, Higa S, Sakoda S, et al. Orthostatic hypotension in familial amyloid polyneuropathy: treatment with DL-threo-3,4-dihydroxyphenylserine. Neurology 1981; 31:1323-6.
10. Kachi T, Iwase S, Mano T, Saito M, Kunimoto M, Sobue I. Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activities in Shy-Drager syndrome. Neurology 1988;38:1091-4.
11. Birkmayer W, Birkmayer G, Lechner H, Riederer P. DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizziness. J Neurol Transmission 1983;58:305-13.
12. Patil PN, Miller DD, Trendelenburg U. Molecular geometry and adrenergic drug activity. Pharmacol Rev 1975;26: 323-92.